LALAINE TIU: Open Payments
NPI 1225173537 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,637 in 69 payments from 12 companies in 2025. Trend: 2023 $1,226 · 2024 $1,290 · 2025 $3,637
Food & beverage: $3,595Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $809 |
| Novo Nordisk Inc | 11 | $559 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $523 |
| Lilly USA, LLC | 8 | $426 |
| Amgen Inc. | 10 | $298 |
| Phathom Pharmaceuticals, Inc. | 2 | $250 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $224 |
| Braeburn Inc. | 4 | $177 |
| Abbott Laboratories | 2 | $168 |
| Corcept Therapeutics | 1 | $125 |
Products named: AIRSUPRA, Ozempic, JARDIANCE, VOQUEZNA, OFEV, BREZTRI, Wegovy, REPATHA.
Industry payments across CA — which companies pay providers there.
